Evidence map›Paper›PMID 40541447›Full record

ReviewRNA (New York, N.Y.)2025

RNA aptamers as tools for the purification and analysis of in vivo assembled ribonucleoproteins.

Daniel G Rocca, Ute Kothe

Abstract readReview
In one paragraph

Review in RNA (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel G RoccaDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, R3T 2N2 Canada.
Ute KotheDepartment of Chemistry, University of Manitoba, Winnipeg, Manitoba, R3T 2N2 Canada ute.kothe@umanitoba.ca.ORCID 0000-0002-2744-7334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large number of ribonucleoprotein (RNP) complexes are being discovered mediating numerous cellular functions. To investigate the composition, structure, and functional mechanism of RNP complexes, it is advantageous to isolate an RNP that was assembled in vivo. This review provides a systematic overview of a versatile and highly effective method to accomplish this task, namely, the purification of RNPs from cells using genetically encoded RNA aptamers. Inserting an RNA aptamer into the RNA of an RNP enables binding of the tagged RNP with high affinity and specificity to a ligand as an effective affinity chromatography purification strategy. Therefore, the purification of RNPs using aptamers has been used successfully to identify heterogenous populations of RNPs forming around a single RNA as well as to characterize intermediates in the formation of complex RNPs such as the ribosome. Here, we discuss in detail the selection of an appropriate RNA aptamer based on the properties of both the aptamer and its ligand, and we describe critical considerations in designing RNP purifications.

Indexed as

Aptamers, NucleotideRibonucleoproteinsAnimalsChromatography, AffinityHumansSELEX Aptamer TechniqueAptamers, NucleotideRibonucleoproteinsaffinity chromatographyfunctional RNAligand bindingRNA–protein interactionRNA structure

Identifiers

PMID40541447
PMCPMC12360210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.